Repligen | RGEN - Stock


Repligen reported $170.46M in Stock for its fiscal quarter ending in December of 2025.





Stock Change Date
Agilent USD 1.06B 34M Dec/2025
Align Technology USD 228.16M 15.59M Sep/2025
Bio Techne USD 205.45M 2.26M Dec/2025
BioMarin Pharmaceutical USD 1.3B 83.29M Dec/2025
Bristol-Myers Squibb USD 2.76B 21M Sep/2025
Bruker USD 1.2B 21.7M Sep/2025
Charles River Laboratories USD 299.1M 3.45M Dec/2025
Danaher USD 2.49B 185M Dec/2025
Dentsply International USD 686M 11M Sep/2025
Exact Sciences USD 166.2M 1.42M Dec/2025
General Electric Aerospace USD 11.87B 201M Dec/2025
Henry Schein USD 2B 90M Dec/2025
Illumina USD 564M 26M Dec/2025
Mettler Toledo International USD 387.23M 14.58M Dec/2025
Myriad Genetics USD 31.6M 2.9M Sep/2025
OraSure Technologies USD 33.4M 26K Sep/2025
Pacific Biosciences Of California USD 53.15M 686K Sep/2025
Pfizer USD 11.47B 201M Sep/2025
Repligen USD 170.46M 10.14M Dec/2025
Revvity USD 379.5M 420K Dec/2025
Standard Biotools USD 25.42M 1.25M Sep/2025
Thermo Fisher Scientific USD 5.43B 320M Dec/2025
Waters USD 572.37M 570K Dec/2025
West Pharmaceutical Services USD 443.9M 5.9M Dec/2025